Top 5 Fertility Clinics: A Data-Based Review of U.S. Providers

The Top 5 Fertility Clinics identified in the 2026 Newsweek and Statista ranking are Columbia University Fertility Center, Weill Cornell Medicine’s Center for Reproductive Medicine, NYU Langone Fertility Center, Brigham and Women’s Hospital Center for Infertility and Reproductive Surgery, and UCSF Center for Reproductive Health at Mission Bay. The ranking covers 140 clinics across 32 states and Washington, D.C., and recognizes providers amid growing use of advanced genomics, artificial intelligence, and laboratory automation. 1

How the national ranking is defined

There is no single official U.S. ranking that determines which fertility clinic is appropriate for every patient. Comparisons commonly involve live-birth outcomes, patient characteristics, treatment scope, accreditation, patient experience, cost, insurance coverage, and geographic access. The Newsweek and Statista ranking evaluated clinics using success rates, patient satisfaction, peer recommendations, and accreditations, rather than relying on one outcome measure alone. 14

Ranking position should therefore be treated as a research reference, not as a clinical recommendation. Infertility treatment depends on the underlying cause, age, medical history, and patient preferences, so a clinic’s national position cannot predict an individual result. The Centers for Disease Control and Prevention and the Society for Assisted Reproductive Technology provide additional outcome-reporting resources that can help place a clinic’s results in context. 678

The five highest-ranked facilities

The following table reproduces the first five entries in America’s Best Fertility Clinics 2026. These facilities are distributed across three major U.S. medical centers: New York City, Boston, and San Francisco. The table shows ranking order and location only, because the supplied ranking does not provide a standardized clinic-by-clinic success-rate percentage. 1

What the leading centers generally provide

Fertility centers may combine diagnostic evaluation with assisted reproductive technology and reproductive surgery. Services identified in the supplied research include in-vitro fertilization, intrauterine insemination, fertility preservation, egg and embryo freezing, donor programs, genetic testing, and treatment for both male and female infertility. NYU Langone’s listed services include donor treatment, fertility preservation, reproductive surgery, and infertility care. 1012

UCSF’s Center for Reproductive Health provides infertility evaluation and treatment, IVF, fertility preservation, and reproductive endocrinology care. Comparable services at other major U.S. providers include donor-egg programs, reproductive endocrinology, genetic testing, and preservation planning. The presence of a service on a clinic’s general catalogue does not establish that every treatment is suitable, available at every location, or covered by a patient’s insurance. 101314

Why success-rate comparisons require caution

Headline IVF percentages can be misleading when they are not separated by age, cycle type, embryo-transfer method, and patient diagnosis. IVF Finder’s research guidance advises examining live-birth rates per transfer rather than pregnancy rates alone, and reviewing age-specific categories including under 35, ages 35 to 37, ages 38 to 40, ages 41 to 42, and over 42. Those distinctions matter because a clinic’s overall result reflects the patients and treatments represented in its reporting. 3

PlainFertility describes a ranking based on the most recently published CDC data available in its dataset, covering 495 reporting U.S. clinics and excluding records with null or zero values for the selected metric. The underlying CDC system can suppress records for confidentiality, sample-size, or quality-control reasons. Consequently, the absence of a figure does not necessarily mean that a clinic lacks activity or has poor outcomes. 25

Eligibility, oversight, and practical constraints

Fertility care is regulated through professional standards, reporting systems, and clinical oversight, but eligibility for a particular treatment remains individualized. Assessment can involve the cause of infertility, age, medical history, reproductive goals, and preferences. Treatment may also differ for individuals or couples using donor eggs or sperm, preserving fertility, managing male-factor infertility, or considering reproductive surgery. 79

Patients may encounter practical constraints involving insurance coverage, out-of-pocket treatment costs, travel distance, appointment availability, laboratory coordination, medication requirements, and emotional support. RESOLVE identifies cost, insurance, support resources, and provider qualifications as relevant selection factors. A nationally recognized facility may still be unsuitable if its treatment scope, location, communication model, or payment arrangements do not match a patient’s circumstances. 8

A structured way to compare clinics

A useful comparison begins with the same questions for each facility: Which age-specific live-birth outcomes are reported? Are results shown by treatment type and transfer method? How many cycles are represented? Which services are performed on site, and which require outside providers? Patients can also ask about reproductive endocrinology expertise, male-factor evaluation, donor treatment, fertility preservation, genetic testing, reproductive surgery, and the process for reviewing records before treatment begins. 36

Additional questions should address laboratory standards, embryo-transfer practices, counseling, communication with care teams, insurance verification, medication coordination, and the handling of complications. SART maintains a clinic directory and ART outcome information for participating clinics, while the CDC publishes clinic-level assisted reproductive technology reports. These sources can supplement, but not replace, a consultation with a qualified specialist who can interpret results for a specific medical history. 56

Interpreting the five clinics in context

The 2026 ranking places three of the five leading facilities in New York City, one in Boston, and one in San Francisco. That geographic concentration reflects the prominence of large academic and hospital-based reproductive medicine programs in the ranking, but it does not establish that other regions lack qualified care. The same ranking recognizes 140 facilities nationally, indicating a broader provider landscape than the five highest positions alone. 1

Columbia, Weill Cornell, NYU Langone, Brigham and Women’s Hospital, and UCSF should therefore be understood as highly ranked reference points within one national assessment. Their ranking is not a guarantee of pregnancy or live birth, and the supplied data does not support declaring one clinic universally superior for every diagnosis or age group. Clinical fit, transparent reporting, oversight, access, and informed discussion remain central to a responsible comparison. 178

Sources

1. Newsweek and Statista, America’s Best Fertility Clinics 2026
2. PlainFertility, Top 10 U.S. Fertility Clinics by Overall CDC ART Success Rate
3. IVF Finder, Best IVF Clinics in the USA 2026
4. NJ.com, New Jersey fertility clinics in the 2026 national ranking
5. Centers for Disease Control and Prevention, ART Fertility Clinic Success Rates
6. Society for Assisted Reproductive Technology
7. American College of Obstetricians and Gynecologists
8. RESOLVE: The National Infertility Association
9. American Society for Reproductive Medicine
10. NYU Langone Health, UCSF Health, CCRM Fertility, and Boston IVF service information